BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

9162 related articles for article (PubMed ID: 1505770)

  • 1. C-myc oncogene expression in ocular melanomas.
    Royds JA; Sharrard RM; Parsons MA; Lawry J; Rees R; Cottam D; Wagner B; Rennie IG
    Graefes Arch Clin Exp Ophthalmol; 1992; 230(4):366-71. PubMed ID: 1505770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p53 expression in uveal malignant melanomas.
    Jay V; Yi Q; Hunter WS; Zielenska M
    Pathology; 1996 Nov; 28(4):306-8. PubMed ID: 9007946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inverse correlation between expression of HLA-B and c-myc in uveal melanoma.
    Blom DJ; Mooy CM; Luyten GP; Kerkvliet S; Ouwerkerk I; Zwinderman AH; Schrier PI; Jager MJ
    J Pathol; 1997 Jan; 181(1):75-9. PubMed ID: 9072006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma.
    Chana JS; Wilson GD; Cree IA; Alexander RA; Myatt N; Neale M; Foss AJ; Hungerford JL
    Br J Ophthalmol; 1999 Jan; 83(1):110-4. PubMed ID: 10209447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estimation of DNA content in uveal melanomas by flow cytometry.
    Rennie IG; Rees RC; Parsons MA; Lawry J; Cottam D
    Eye (Lond); 1989; 3 ( Pt 5)():611-7. PubMed ID: 2630338
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical and prognostic analysis of apoptosis and proliferation in uveal melanoma.
    Mooy CM; Luyten GP; de Jong PT; Luider TM; Stijnen T; van de Ham F; van Vroonhoven CC; Bosman FT
    Am J Pathol; 1995 Oct; 147(4):1097-104. PubMed ID: 7573354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PC-10 immunostaining of proliferating cell nuclear antigen in posterior uveal melanoma. Enucleation versus enucleation postirradiation groups.
    Pe'er J; Gnessin H; Shargal Y; Livni N
    Ophthalmology; 1994 Jan; 101(1):56-62. PubMed ID: 7905616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. KI-67 immunopositivity in choroidal and ciliary body melanoma with respect to nucleolar diameter and other prognostic factors.
    Al-Jamal RT; Kivelä T
    Curr Eye Res; 2006 Jan; 31(1):57-67. PubMed ID: 16421020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical expression of S-100 beta in choroidal melanomas.
    Martins MC; Scull JJ; Alcocer CE; Deschênes J; Antecka E; Burnier MN
    Can J Ophthalmol; 1997 Oct; 32(6):378-81. PubMed ID: 9363341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma.
    Coupland SE; Bechrakis N; Schüler A; Anagnostopoulos I; Hummel M; Bornfeld N; Stein H
    Br J Ophthalmol; 1998 Aug; 82(8):961-70. PubMed ID: 9828785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical investigations of adult intraocular medulloepitheliomas.
    Jakobiec FA; Rose MF; Trief D; Stagner AM; Kim I; Gragoudas ES
    Clin Exp Ophthalmol; 2015; 43(4):379-85. PubMed ID: 25251824
    [No Abstract]   [Full Text] [Related]  

  • 12. [Monoclonal antibody HMB-45 in diagnosis of intra-ocular melanoma].
    Rohrbach JM; Steuhl KP; Thanos S
    Klin Monbl Augenheilkd; 1991 Oct; 199(4):274-7. PubMed ID: 1762354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Premetastatic uveal melanoma cells do not express laminin receptors.
    Rohrbach JM; Wild M; Riedinger C; Kreissig I; Thiel HJ
    Ger J Ophthalmol; 1994 May; 3(3):144-7. PubMed ID: 8038682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of cancer-testis antigens (MAGE-A1, MAGE-A3/6, MAGE-A4, MAGE-C1 and NY-ESO-1) in primary human uveal and conjunctival melanoma.
    Errington JA; Conway RM; Walsh-Conway N; Browning J; Freyer C; Cebon J; Madigan MC
    Br J Ophthalmol; 2012 Mar; 96(3):451-8. PubMed ID: 22190731
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prognostic significance of c-myc oncogene expression in uveal melanoma.
    Chana JS; Cree IA; Foss AJ; Hungerford JL; Wilson GD
    Melanoma Res; 1998 Apr; 8(2):139-44. PubMed ID: 9610866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraocular lymphatics in ciliary body melanomas with extraocular extension: functional for lymphatic spread?
    Heindl LM; Hofmann TN; Schrödl F; Holbach LM; Kruse FE; Cursiefen C
    Arch Ophthalmol; 2010 Aug; 128(8):1001-8. PubMed ID: 20697000
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The clinical significance of c-myc oncogene expression in melanomas of the scalp.
    Chana JS; Grover R; Wilson GD; Hudson DA; Forders M; Sanders R; Grobbelaar AO
    Br J Plast Surg; 1998 Apr; 51(3):191-4. PubMed ID: 9664877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ki-67 immunostaining in uveal melanoma. The effect of pre-enucleation radiotherapy.
    Mooy CM; de Jong PT; Van der Kwast TH; Mulder PG; Jager MJ; Ruiter DJ
    Ophthalmology; 1990 Oct; 97(10):1275-80. PubMed ID: 2243677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melanocortin 1 receptor is expressed by uveal malignant melanoma and can be considered a new target for diagnosis and immunotherapy.
    López MN; Pereda C; Ramírez M; Mendoza-Naranjo A; Serrano A; Ferreira A; Poblete R; Kalergis AM; Kiessling R; Salazar-Onfray F
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1219-27. PubMed ID: 17325166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of cell cycle related proteins in a rapidly growing uveal malignant melanoma.
    Honda S; Hirai T; Handa JT; Okuno T; Saito I
    Retina; 2004 Aug; 24(4):646-9. PubMed ID: 15300098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 459.